Some data were available for CDKN2A, GSTP1, CDKN1A and some other genes [32–35], whereby these genes were reported to be downregulated by promoter CpG-island hypermethylation in HCC. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.